215.09
Natera Inc stock is traded at $215.09, with a volume of 1.90M.
It is up +4.02% in the last 24 hours and up +4.99% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$206.77
Open:
$208.54
24h Volume:
1.90M
Relative Volume:
1.52
Market Cap:
$30.71B
Revenue:
$2.31B
Net Income/Loss:
$-208.16M
P/E Ratio:
-139.98
EPS:
-1.5366
Net Cash Flow:
$76.11M
1W Performance:
+10.44%
1M Performance:
+4.99%
6M Performance:
+8.37%
1Y Performance:
+38.32%
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NTRA
Natera Inc
|
215.09 | 29.52B | 2.31B | -208.16M | 76.11M | -1.5366 |
|
TMO
Thermo Fisher Scientific Inc
|
472.95 | 173.46B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
174.92 | 123.60B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
579.23 | 44.71B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
349.53 | 33.65B | 3.77B | 449.25M | 516.49M | 8.7322 |
|
A
Agilent Technologies Inc
|
117.69 | 33.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Initiated | William Blair | Outperform |
| Jan-07-26 | Initiated | Citigroup | Buy |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-27-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-22-25 | Resumed | Wells Fargo | Equal Weight |
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Natera Insider Sold Shares Worth $693,560, According to a Recent SEC Filing - marketscreener.com
What To Expect From Natera’s (NTRA) Q4 Earnings - StockStory
Natera president John Fesko sells $59,992 of NTRA shares - Investing.com
Natera chief legal officer Daniel Rabinowitz sells $68,032 in shares - Investing.com
Natera president Solomon Moshkevich sells $693,559 in shares By Investing.com - Investing.com South Africa
Natera (NASDAQ: NTRA) president disposes 3,405 shares in planned sales - Stock Titan
Natera (NTRA) CFO sells 795 shares to cover RSU tax via 10b5-1 plan - Stock Titan
Natera CFO Michael Brophy sells $165,984 in company stock - Investing.com
Natera co-founder Sheena Jonathan sells $22,059 in common stock - Investing.com
Natera president Solomon Moshkevich sells $693,559 in shares - Investing.com
Natera CEO Steven Chapman disposes of $185,956 in company stock - Investing.com
Natera's Signatera data suggests select breast cancer patients could skip surgery - MSN
Michael Brophy files Form 144 on NTRA stock sales (NTRA) - Stock Titan
Have Insiders Sold Natera Shares Recently? - simplywall.st
Don't Ignore The Insider Selling In Natera - Moomoo
MSN Money - MSN
Natera Inc. (NTRA): Billionaire Tom Steyer’s Stock Pick with Huge Upside Potential - Yahoo Finance
Liquidity Mapping Around (NTRA) Price Events - Stock Traders Daily
Natera, Inc. $NTRA Shares Acquired by UBS Group AG - MarketBeat
Will Expanded Prospera Transplant Data at ISHLT 2026 Change Natera's (NTRA) Molecular Diagnostics Narrative? - simplywall.st
William Blair Initiates Natera (NTRA) With Outperform - Insider Monkey
Kornitzer Capital Management Inc. KS Has $11.44 Million Position in Natera, Inc. $NTRA - MarketBeat
Jennison Associates LLC Has $44.89 Million Stock Position in Natera, Inc. $NTRA - MarketBeat
Earnings Preview: Natera to Report Financial Results Post-market on May 07 - Moomoo
Artemis Investment Management LLP Sells 65,292 Shares of Natera, Inc. $NTRA - MarketBeat
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth - The National Law Review
Form 144: 3,000 Performance Shares notice (NTRA) via Morgan Stanley - Stock Titan
Natera, Inc. $NTRA Shares Sold by Comerica Bank - MarketBeat
NTRA Stock Chart | NATERA INC (NASDAQ:NTRA) - ChartMill
NTRA SEC FilingsNatera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Exploring High Growth US Tech Stocks This April 2026 - simplywall.st
Natera to Report its First Quarter Results on May 7, 2026 - BioSpace
Vanguard Capital Management holds 7.21M Natera shares (NTRA) in Schedule 13G - Stock Titan
After the close, Natera will post Q1 results and host a 4:30 ET call - Stock Titan
Natera (NTRA) Projected to Post Earnings on Thursday - MarketBeat
Natera (NASDAQ:NTRA) CFO Sells $594,781.80 in Stock - MarketBeat
Natera (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 1,993 Shares - MarketBeat
Natera SEC and chief legal officer Daniel Rabinowitz sells $379,811 in shares - Investing.com India
Natera CEO Steven Chapman sells $1.19 million in shares By Investing.com - Investing.com India
Natera CFO Brophy sells $1m in shares; some for tax obligations - Investing.com Nigeria
Natera CEO Steven Chapman sells $1.19 million in shares - Investing.com
Steven Leonard Chapman Sells 5,838 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera president John Fesko sells $344,516 in company stock By Investing.com - Investing.com India
Natera president Moshkevich sells $445,340 in shares By Investing.com - Investing.com India
Natera (NTRA) CFO logs 5,063-share pre-planned sale tied to RSU taxes - Stock Titan
John Fesko Sells 1,688 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Insider Selling: Natera (NASDAQ:NTRA) Insider Sells 2,182 Shares of Stock - MarketBeat
Natera co-founder Sheena Jonathan sells $699,692 in company stock By Investing.com - Investing.com Australia
Natera co-founder Sheena Jonathan sells $699,692 in company stock - Investing.com
Natera president Moshkevich sells $445,340 in shares - Investing.com
Natera president John Fesko sells $344,516 in company stock - Investing.com
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):